ADVM icon

Adverum Biotechnologies

77 hedge funds and large institutions have $70M invested in Adverum Biotechnologies in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 11 increasing their positions, 27 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less funds holding

Funds holding:

18% less capital invested

Capital invested by funds: $85.9M → $70M (-$15.9M)

45% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 29

59% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 27

Holders
77
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.9M
Puts
$13K
Net Calls
Net Calls Change

Top Buyers

1 +$8.41M
2 +$2.07M
3 +$1.25M
4
NM
Newtyn Management
New York
+$1.24M
5
Renaissance Technologies
Renaissance Technologies
New York
+$836K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$13M
2
$8.84M
3
$7.86M
4
$6.08M
5
$4.99M
6
$3.99M
7
$3.6M
8
$2.07M
9
$1.96M
10
$1.81M
11
$1.4M
12
$1.31M
13
$1.26M
14
$1.25M
15
$1.24M
16
$1.13M
17
$903K
18
$705K
19
$604K
20
$558K
21
$536K
22
$504K
23
$425K
24
$390K
25
$387K